000 | 01821 a2200553 4500 | ||
---|---|---|---|
005 | 20250517001533.0 | ||
264 | 0 | _c20150625 | |
008 | 201506s 0 0 eng d | ||
022 | _a1932-6203 | ||
024 | 7 |
_a10.1371/journal.pone.0111246 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZhang, Jian | |
245 | 0 | 0 |
_aHepatocyte growth factor modification enhances the anti-arrhythmic properties of human bone marrow-derived mesenchymal stem cells. _h[electronic resource] |
260 |
_bPloS one _c2014 |
||
300 |
_ae111246 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aApoptosis |
650 | 0 | 4 |
_aArrhythmias, Cardiac _xpathology |
650 | 0 | 4 |
_aAutonomic Nervous System _xphysiopathology |
650 | 0 | 4 |
_aBone Marrow Cells _xcytology |
650 | 0 | 4 | _aCell Survival |
650 | 0 | 4 | _aElectric Stimulation |
650 | 0 | 4 | _aGene Expression Regulation |
650 | 0 | 4 |
_aHeart Ventricles _xphysiopathology |
650 | 0 | 4 |
_aHepatocyte Growth Factor _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMesenchymal Stem Cell Transplantation |
650 | 0 | 4 |
_aMesenchymal Stem Cells _xcytology |
650 | 0 | 4 |
_aMyocardial Infarction _xpathology |
650 | 0 | 4 | _aNeovascularization, Physiologic |
650 | 0 | 4 | _aSwine |
700 | 1 | _aWang, Lin-Lin | |
700 | 1 | _aDu, Wei | |
700 | 1 | _aYu, Yi-Chao | |
700 | 1 | _aJu, Wei-Zhu | |
700 | 1 | _aMan, Yi-Long | |
700 | 1 | _aLi, Xiao-Rong | |
700 | 1 | _aChen, Yan | |
700 | 1 | _aWang, Zi-Dun | |
700 | 1 | _aGu, Wei-Juan | |
700 | 1 | _aZhang, Feng-Xiang | |
700 | 1 | _aWang, Hua | |
700 | 1 | _aWu, Chu-Tse | |
700 | 1 | _aCao, Ke-Jiang | |
773 | 0 |
_tPloS one _gvol. 9 _gno. 10 _gp. e111246 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0111246 _zAvailable from publisher's website |
999 |
_c24319895 _d24319895 |